DuPont Tate & Lyle Bio Products is celebrating ten years since the first commercial shipments of its biomaterial, bio-based 1,3-propanediol. Four years after the first shipment it announced an expansion increasing capacity by 35 per cent at its facility in Loudon, Tennessee.
“This joint venture started as a revolutionary innovation project that applied the tools of modern biotechnology to make high-performance biomaterials in a much more sustainable way than traditional petrochemistry,” said Michael Saltzberg, global business director of biomaterials for DuPont. “Its track record of success has inspired the academic and industrial science community around the world to invest in industrial biotech and is a case study of how to successfully innovate in this space.
“Our partnership with DuPont is a great example of bringing the best of two organisations together to create a first to market product and process that continues to demonstrate versatility and functionality in the global marketplace,” said Greg Wenndt, vice president and general manager, industrial starch and bioventures, Tate & Lyle. “We are proud of the success we’ve built together and share our congratulations with our DuPont partners and the DuPont Tate & Lyle teams around the world for achieving a decade of great work and continued innovation.”
